Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade

Prostate cancer (PCa) is the most common malignancy among Western men and the second leading-cause of cancer related deaths. For men who develop metastatic castration resistant PCa (mCRPC), survival is limited, making the identification of novel therapies for mCRPC critical. We have found that defic...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaig, Thomas W., Salzmann-Sullivan, Maren, Su, Lih-Jen, Zhang, Zhiyong, Joshi, Molishree, Gijón, Miguel A., Kim, Jihye, Arcaroli, John J., Van Bokhoven, Adrie, Lucia, M. Scott, La Rosa, Francisco G., Schlaepfer, Isabel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593544/
https://www.ncbi.nlm.nih.gov/pubmed/28915573
http://dx.doi.org/10.18632/oncotarget.17359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593544/
https://www.ncbi.nlm.nih.gov/pubmed/28915573
http://dx.doi.org/10.18632/oncotarget.17359

Ejemplares similares